Items tagged with Access
WHO, stakeholders take ‘first step’ on fair pricing for medicines (post)
The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants.
WHO releases 10-year review report chapter focusing on access to medicines (post)
Access to medicines: making market forces serve the poor
Child-friendly TB tablets to be introduced in India (post)
There is good news for children suffering from tuberculosis as the government has started the rollout of the world's first easily-dissolvable and flavoured drug in five states as part of a pilot programme.
Major research funders and international NGOs to implement WHO standards on reporting clinical trial results (post)
18 May 2017 | GENEVA - Some of the world’s largest funders of medical research and international non-governmental organizations today agreed on new standards that will require all clinical trials they fund or support to be registered and the results disclosed publicly.
Population implications of the use of bedaquiline in people with extensively drug-resistant TB: are fears of resistance justified? (post)
Summary
MPP video: Working together for better treatment options (post)
The Medicines Patent Pool (MPP) released a short film, in which MPP’s stakeholders from industry, government, civil society and patient groups discuss the foundation’s innovative business model, achievements and future plans to increase access to HIV, hepatitis C and TB treatment within the context of the UN Sustainable Development Goals.
Media coverage of the 70th World Health Assembly (post)
Intellectual Property Watch news coverage of the 70th World Health Assembly:
Tackling TB in the Asia Pacific (post)
Tuberculosis is the number one cause of death from infectious disease worldwide. While Australia has one of the lowest rates of tuberculosis globally, more than half of the world's multidrug-resistant cases are found throughout countries in our region. And Australians are playing a critical role in trying to end the global tuberculosis epidemic by 2030.
Seoul OKs Eugene Bell Foundation's bid to send TB medications, other materials to North Korea (post)
SEOUL, June 27 (Yonhap) -- South Korea's unification ministry has approved the Eugene Bell Foundation Korea's application to send medications for tuberculosis and materials to build hospital wards to North Korea, an official said Tuesday.
Denying access to bedaqualine in India costs lives (post)
As physicians managing the so-called Patna patient—an 18-year-old woman who took the Indian government to court after being denied access to bedaqualine—we commend Amber Kunkel and colleagues on their forthright article.1 The woman's case is emblematic of the desperation of the many patients with advanced drug resistance and with few therapeutic options that we encounter in our clinic. India's National Tuberculosis Program's (RNTCP) insistence on reserving bedaqualine for patients who have at least three susceptible drugs in the background regimen,2 denies this drug to the very patients who would most benefit from it, especially since it doubles the chance of a cure.3 It worries us that such patients, denied access to a life-saving drug, are compelled to move the judiciary to access it. The theoretical fear of protecting a drug has sadly taken precedence over protecting lives.
Page 29 of 83 · Total posts: 0
←First 28 29 30 Last→